Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis.

Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis. N Engl J Med. 2012 Sep 20; 367(12):1098-107.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.